# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Cleopatra (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-AC003-SYN
- Date: 2026-03-17
- Fictional facility: St. Posthumous Health Center
- Fictional author: Nefeli Arvanitis-Osei, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Prenatal visit at 11 weeks after the first-trimester ultrasound; maternal-fetal medicine consultation today. **S**

## History of present illness

Cleopatra returns at 11 weeks 0 days by her last period. This morning's ultrasound with Dr. Haddad-Thornbury of maternal-fetal medicine showed two live fetuses with a thick dividing membrane and a twin-peak sign: a dichorionic diamniotic twin pregnancy. The crown-rump lengths (45 and 46 mm) agree with her dates within three days, so her due date is unchanged. There are no fibroids and no features of a molar pregnancy. The nausea has eased on doxylamine with pyridoxine; she vomits about once a day and keeps food and fluids down (PUQE 7). She takes the prenatal vitamin and ferrous sulfate every other day. She has had no bleeding or pain. She was surprised by the news of twins and is pleased, though she is already thinking about how she will manage her work. Her first-visit results are back. **S**

| Element | Detail |
|---|---|
| Ultrasound | Dichorionic diamniotic twins; dates confirmed; no fibroids or molar features |
| Nausea | Easing; vomits about once a day; PUQE 7 |
| Medicines | Prenatal vitamin, ferrous sulfate every other day, doxylamine with pyridoxine at bedtime |
| Symptoms | No bleeding or pain |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired |
| Gastrointestinal | Positive | Nausea, easing; vomiting about once a day |
| Genitourinary | Negative | No bleeding, discharge, or urinary symptoms |
| Psychiatric | Negative | Surprised and pleased; some worry about work |

4 systems reviewed. **S**

## Current medications

- Prenatal vitamin containing folic acid 0.4 mg, one tablet by mouth daily **S**
- Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other day **S**
- Doxylamine succinate 10 mg / pyridoxine hydrochloride 10 mg delayed-release tablet, two tablets by mouth at bedtime **S**

## Allergies

- No known allergy **S**

## Objective

BP 106/64 mmHg; pulse 86 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 58.2 kg; BMI 21.4 kg/m². All vital signs are synthetic.

Crown-rump length, twin A: 45 mm; Crown-rump length, twin B: 46 mm; Nuchal translucency, twin A: 1.6 mm; Nuchal translucency, twin B: 1.8 mm. All results are synthetic.

## Physical examination

| System | Finding |
|---|---|
| General | Well |
| Abdomen | Uterus palpable just above the pubic bone, about 14 weeks in size; non-tender |
| Fetal | Two fetal hearts seen on this morning's scan |
| Urine dipstick | Protein negative; ketones negative |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Uterus larger than dates: resolved** (O26.841). Explained by a twin pregnancy. The dates are confirmed: the crown-rump lengths agree with her last period within three days, well inside the seven days that would call for redating before 14 weeks. No fibroids or molar features. **S**
   - Resolved: the diagnosis is recorded as a dichorionic diamniotic twin pregnancy (PRB-004).
2. **Twin pregnancy, dichorionic diamniotic** (O30.041). Chorionicity is settled now, before 14 weeks, when the twin-peak sign is most reliable. A dichorionic pregnancy carries no risk of twin-to-twin transfusion, but twins raise the risks of preterm birth, preeclampsia, growth problems, gestational diabetes, anemia, and postpartum hemorrhage. Intake results: blood group A, RhD positive, antibody screen negative; rubella immune; hepatitis B surface antigen, HIV, syphilis, and hepatitis C negative; urine culture no growth. **S**
   - Aneuploidy screening: nuchal translucency 1.6 and 1.8 mm today; cell-free DNA drawn today, as she chose; chorionic villus sampling and amniocentesis remain available.
   - Aspirin 81 mg at bedtime from 12 weeks, next week, until delivery.
   - Detailed anatomy scans at 19 weeks, then growth scans every four weeks.
   - Visits every two to four weeks.
   - Weight gain of about 17 to 25 kg; an extra 300 to 600 calories a day with protein and iron-rich foods.
   - Teaching on the signs of preterm labor; no bed rest or activity restriction is needed for twins alone.
3. **Nausea and vomiting of pregnancy** (O21.9). Improving on doxylamine with pyridoxine; no weight loss. **S**
   - Continue at bedtime; stop when the nausea settles.
4. **Iron deficiency anemia in pregnancy** (O99.011). Twins increase iron needs; she is taking alternate-day iron without side effects. **S**
   - Continue ferrous sulfate every other day.
   - Blood count and ferritin at 19 weeks; intravenous iron if they do not improve.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure and urine protein | Every prenatal visit | Completed today | 106/64 mmHg; urine protein negative |
| Examination | Fetal hearts and fundal height | Every prenatal visit | Completed today | Two live fetuses on the scan; uterus about 14 weeks in size |
| Examination | Weight gain (about 17 to 25 kg for twins from a normal BMI) | Every prenatal visit | Completed today | 58.2 kg, up 0.2 kg since intake |
| Imaging | Dating and chorionicity scan | Before 14 weeks in every twin pregnancy | Completed today | Dichorionic diamniotic; crown-rump lengths 45 and 46 mm; dates confirmed |
| Imaging | Nuchal translucency for each fetus | At 11 to 14 weeks, as she chooses | Completed today | 1.6 mm (twin A) and 1.8 mm (twin B) |
| Laboratory | Cell-free DNA screening | From 10 weeks, as she chooses | Ordered | Drawn today; in twins it cannot say which twin is affected and fails more often |
| Laboratory | First prenatal tests (blood group, antibody screen, rubella, hepatitis B, HIV, syphilis, hepatitis C, urine culture) | At the first prenatal visit | Completed today | Reviewed today: RhD positive; all normal or negative |
| Laboratory | Hemoglobin and ferritin | At intake, at the anatomy-scan visit, at 24 to 28 weeks, and in the third trimester | Up to date | Hemoglobin 10.8 g/dL and ferritin 14 ng/mL at intake; next at 19 weeks |
| Medication safety | Low-dose aspirin | Daily from 12 weeks until delivery; review at every visit | Ordered | Prescribed today to start at 12 weeks |
| Referral | Maternal-fetal medicine consultation | Early in a twin pregnancy | Completed today | Seen today; surveillance plan agreed |
| Imaging | Detailed anatomy scans | At 18 to 22 weeks | Due | Booked for 19 weeks |
| Survey | Perinatal mood screen (EPDS) | Each trimester | Up to date | 6 at intake, item 10 scored 0; next in the second trimester |
| Self-management | Preterm labor warning signs | Every prenatal visit | Completed today | Signs of preterm labor taught; no activity restriction |

## Goal progress

- The cause of the large uterus and the dating of the pregnancy established at the 11-week scan. Outcome by 2026-03-17: Dichorionic diamniotic twins; dating by her last period confirmed by the crown-rump lengths. **S**
- An informed choice about aneuploidy screening by 14 weeks. Outcome by 2026-03-17: Chose nuchal translucency for each twin with cell-free DNA; declined diagnostic testing for now. **S**
- Hemoglobin and ferritin in the normal range for pregnancy by the third trimester. In progress; target 2026-08-18. **S**
- Growth discordance under 20 percent at every growth scan. In progress; target 2026-08-18. **S**
- A written delivery plan agreed by 34 weeks. In progress; target 2026-08-18. **S**

## Guideline basis

- Multifetal Gestations: Twin, Triplet, and Higher-Order Multifetal Pregnancies: ACOG Practice Bulletin, Number 231 (2021), American College of Obstetricians and Gynecologists and Society for Maternal-Fetal Medicine (Obstetrics & Gynecology)
- Prediction and Prevention of Spontaneous Preterm Birth: ACOG Practice Bulletin, Number 234 (2021), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- Committee Opinion No 700: Methods for Estimating the Due Date (2017), American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, and Society for Maternal-Fetal Medicine (Obstetrics & Gynecology)
- Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226 (2020), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- Anemia in Pregnancy: ACOG Practice Bulletin, Number 233 (2021), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication (2021), U.S. Preventive Services Task Force

## Follow-up

- Prenatal visit with the anatomy scans at 19 weeks; sooner for bleeding, pain, or vomiting that stops her keeping fluids down. **S**
- Next scheduled visit 2026-05-12: prenatal visit at 19 weeks with the detailed anatomy scans and cervical length. **S**
